You are currently on the new version of our website. Access the old version .

458 Results Found

  • Article
  • Open Access
4 Citations
2,304 Views
17 Pages

14 January 2023

Structured catalytic membranes with high porosity and a low pressure drop are particularly suitable for industrial processes carried out at high space velocities. One of these processes is the catalytic total oxidation of volatile organic compounds,...

  • Review
  • Open Access
14 Citations
4,967 Views
22 Pages

Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives

  • Federica De Castro,
  • Erika Stefàno,
  • Erik De Luca,
  • Michele Benedetti and
  • Francesco Paolo Fanizzi

Nucleoside analogues (NAs) are a family of compounds which include a variety of purine and pyrimidine derivatives, widely used as anticancer and antiviral agents. For their ability to compete with physiological nucleosides, NAs act as antimetabolites...

  • Article
  • Open Access
12 Citations
9,816 Views
25 Pages

Neurotoxic Effects of Platinum Compounds: Studies in vivo on Intracellular Calcium Homeostasis in the Immature Central Nervous System

  • Graziella Bernocchi,
  • Francesco P. Fanizzi,
  • Sandra A. De Pascali,
  • Valeria M. Piccolini,
  • Caterina Gasperini,
  • Violetta Insolia and
  • Maria Grazia Bottone

19 June 2015

Platinum compounds cause significant clinical neurotoxicity. Several studies highlight neurological complications especially in paediatric oncology patients with Central Nervous System (CNS) and non-CNS malignancies. To understand the toxicity mechan...

  • Article
  • Open Access
1 Citations
1,304 Views
24 Pages

17 December 2024

Cisplatin-based platinum compounds are important clinical chemotherapeutic agents that participate in most tumor chemotherapy regimens. Through density-functional theory calculations, the formation and stability of the inorganic oxide carrier, the me...

  • Article
  • Open Access
7 Citations
2,569 Views
14 Pages

6 May 2020

Platinum compounds are anti-cancer drugs and can bind to canonical purine bases, mainly guanine, found within double helical DNA. Platinum compounds can be transferred directly to pathologically altered sites in a specific and site-oriented manner by...

  • Article
  • Open Access
8 Citations
3,961 Views
14 Pages

Reaction with Proteins of a Five-Coordinate Platinum(II) Compound

  • Giarita Ferraro,
  • Tiziano Marzo,
  • Maria Elena Cucciolito,
  • Francesco Ruffo,
  • Luigi Messori and
  • Antonello Merlino

Stable five-coordinate Pt(II) complexes have been highlighted as a promising and original platform for the development of new cytotoxic drugs. Their interaction with proteins has been scarcely studied. Here, the reactivity of the five-coordinate Pt(I...

  • Article
  • Open Access
10 Citations
4,016 Views
20 Pages

In Vitro Nephrotoxicity Studies of Established and Experimental Platinum-Based Compounds

  • Sarah Schoch,
  • Vasily Sen,
  • Walburgis Brenner,
  • Andrea Hartwig and
  • Beate Köberle

Cisplatin is one of the most commonly used drugs for the treatment of various solid cancers. However, its efficacy is restricted by severe side effects, especially dose-limiting nephrotoxicity. New platinum-based compounds are designed to overcome th...

  • Review
  • Open Access
16 Citations
9,538 Views
17 Pages

21 March 2014

This review deals with the reactions of diarylplatinum(II) complexes with N-donor ligands to produce a variety of cycloplatinated compounds including endo-five-, endo-seven-, endo-six- or exo-five-membered platinacycles. The observed reactions resul...

  • Article
  • Open Access
1 Citations
2,855 Views
15 Pages

2 November 2018

Employing a two-orbital extended Peierls–Hubbard model, we demonstrate the photomanipulation of mixed-valent states in platinum-halide ladder compounds. There are two types of interchain valence arrangements, namely in-phase and out-of-phase ty...

  • Article
  • Open Access
8 Citations
3,248 Views
11 Pages

Early and Long-Term Ototoxicity Noted in Children Due to Platinum Compounds: Prevalence and Risk Factors

  • Alberto Romano,
  • Serena Rivetti,
  • Francesca Brigato,
  • Stefano Mastrangelo,
  • Giorgio Attinà,
  • Palma Maurizi,
  • Jacopo Galli,
  • Anna Rita Fetoni and
  • Antonio Ruggiero

Background: Platinum compounds are a group of fundamental chemotherapeutics used in the treatment of solid tumors, but they are burdened by side effects, such as ototoxicity. The objective of this study was to evaluate the incidence of ototoxicity ca...

  • Article
  • Open Access
2 Citations
2,231 Views
14 Pages

Specific IgE and Basophil Activation Test by Microarray: A Promising Tool for Diagnosis of Platinum Compound Hypersensitivity Reactions

  • Carlos Fernández-Lozano,
  • Claudia Geraldine Rita,
  • Alicia Barra-Castro,
  • Belén de la Hoz Caballer,
  • Ernesto Roldán,
  • Cristina Pueyo López,
  • Javier Martinez-Botas and
  • María Pilar Berges-Gimeno

Drug hypersensitivity reactions (DHRs) to platinum-based compounds (PCs) are on the rise, and their personalized and safe management is essential to enable first-line treatment for these cancer patients. This study aimed to evaluate the usefulness of...

  • Article
  • Open Access
6 Citations
2,851 Views
20 Pages

17 May 2022

Platinum anticancer drugs inhibit the division of cancer cells through a DNA binding mechanism. The bimetallic platinum compounds have a possibility for blocking DNA replication via the cross-linking of DNA functional groups at different distances. M...

  • Feature Paper
  • Communication
  • Open Access
4 Citations
3,005 Views
9 Pages

Catalytic Performances of Platinum Containing PLLA Macrocomplex in the Hydrogenation of α,β-Unsaturated Carbonyl Compounds

  • Mattia Bartoli,
  • Luca Rosi,
  • Benedetta Mini,
  • Giorgio Petrucci,
  • Elisa Passaglia and
  • Marco Frediani

8 August 2019

The synthesis of a bipyridine poly(lactic acid) carboxylic end-capped macroligand coordinated to a platinum center was reported. The reaction between the metal ion and the polymeric ligand was run in a very efficient way through a one-step synthesis...

  • Review
  • Open Access
52 Citations
7,230 Views
15 Pages

Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer

  • Alberto Romano,
  • Michele Antonio Capozza,
  • Stefano Mastrangelo,
  • Palma Maurizi,
  • Silvia Triarico,
  • Rolando Rolesi,
  • Giorgio Attinà,
  • Anna Rita Fetoni and
  • Antonio Ruggiero

17 May 2020

Platinum compounds are a group of chemotherapeutic agents included in many pediatric and adult oncologic treatment protocols. The main platinum compounds are cisplatin, carboplatin, and oxaliplatin. Their use in clinical practice has greatly improved...

  • Review
  • Open Access
22 Citations
4,045 Views
14 Pages

20 February 2022

Gender medicine in the field of oncology is an under-researched area, despite the existing evidence towards gender-dependent response to therapy and treatment-induced adverse effects. Oncological treatment aims to fulfil its main goal of achieving hi...

  • Article
  • Open Access
13 Citations
3,141 Views
18 Pages

Continuing our studies on the mechanisms underlying the cytotoxicity of potential drugs, we have described several aspects of the in vitro anticancer activity of ruthenium(II) and platinum(II) complexes with bioactive, synthetic aminoflavone ligands....

  • Article
  • Open Access
15 Citations
3,820 Views
19 Pages

Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with O,S Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues

  • Jana Hildebrandt,
  • Norman Häfner,
  • Helmar Görls,
  • Marie-Christin Barth,
  • Matthias Dürst,
  • Ingo B. Runnebaum and
  • Wolfgang Weigand

(1) Background: Since the discovery of cisplatin’s cytotoxic properties, platinum(II) compounds have attracted much interest in the field of anticancer drug development. Over the last few years, classical structure–activity relationships...

  • Article
  • Open Access
2 Citations
3,852 Views
13 Pages

Wireframe DNA Origami for the Cellular Delivery of Platinum(II)-Based Drugs

  • Erik De Luca,
  • Yang Wang,
  • Igor Baars,
  • Federica De Castro,
  • Marco Lolaico,
  • Danilo Migoni,
  • Cosimo Ducani,
  • Michele Benedetti,
  • Björn Högberg and
  • Francesco Paolo Fanizzi

24 November 2023

The DNA origami method has revolutionized the field of DNA nanotechnology since its introduction. These nanostructures, with their customizable shape and size, addressability, nontoxicity, and capacity to carry bioactive molecules, are promising vehi...

  • Article
  • Open Access
17 Citations
4,189 Views
15 Pages

24 August 2021

Maximum benefits of chemoradiation therapy with platinum-based compounds are expected if the radiation and the drug are localized simultaneously in cancer cells. To optimize this concomitant effect, we developed the novel chemoradiotherapeutic agent...

  • Article
  • Open Access
36 Citations
3,667 Views
13 Pages

A Comparative Study of the Effects of Platinum (II) Complexes on β-Amyloid Aggregation: Potential Neurodrug Applications

  • Sara La Manna,
  • Daniele Florio,
  • Ilaria Iacobucci,
  • Fabiana Napolitano,
  • Ilaria De Benedictis,
  • Anna Maria Malfitano,
  • Maria Monti,
  • Mauro Ravera,
  • Elisabetta Gabano and
  • Daniela Marasco

Herein the effects of three platinum complexes, namely (SP-4-2)-(2,2′-bipyridine)dichloridoplatinum(II), Pt-bpy, (SP-4-2)-dichlorido(1,10-phenanthroline) platinum(II), Pt-phen, and (SP-4-2)-chlorido(2,2′:6′,2′′-terpyridine)platinum(II) chloride, Pt-t...

  • Article
  • Open Access
3 Citations
1,642 Views
16 Pages

Compatibility of Nucleobases Containing Pt(II) Complexes with Red Blood Cells for Possible Drug Delivery Applications

  • Federica De Castro,
  • Erika Stefàno,
  • Francesco Paolo Fanizzi,
  • Riccardo Di Corato,
  • Pasant Abdalla,
  • Francesca Luchetti,
  • Maria Gemma Nasoni,
  • Rosaria Rinaldi,
  • Mauro Magnani and
  • Antonella Antonelli
  • + 1 author

22 September 2023

The therapeutic advantages of some platinum complexes as major anticancer chemotherapeutic agents and of nucleoside analogue-based compounds as essential antiviral/antitumor drugs are widely recognized. Red blood cells (RBCs) offer a potential new st...

  • Article
  • Open Access
15 Citations
7,510 Views
16 Pages

26 August 2014

The divalent complex [{Pt(bzq)(μ-L)}2] (1) [Hbzq = benzo[h]quinolone, HL = CF3C4H2N2SH: 4-(trifluoromethyl)pyrimidine-2-thiol] was obtained from equimolar amounts of [Pt(bzq)(NCMe)2]ClO4 and 4-(trifluoromethyl)pyrimidine-2-thiol with an excess of NE...

  • Article
  • Open Access
13 Citations
2,992 Views
9 Pages

A Novel Class of Cyclometalated Platinum(II) Complexes for Solution-Processable OLEDs

  • Dominique Roberto,
  • Alessia Colombo,
  • Claudia Dragonetti,
  • Francesco Fagnani,
  • Massimo Cocchi and
  • Daniele Marinotto

13 August 2022

Substitution of the chlorido ligand of cyclometalated [Pt (5-R-1,3-di(2-pyridyl) benzene)Cl] (R = methyl, mesityl, 2-thienyl, or 4-diphenylamino-phenyl) by 4-phenylthiazole-2-thiolate leads to related thiolato complexes, which were fully characterize...

  • Review
  • Open Access
26 Citations
4,597 Views
33 Pages

Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments

  • Ester Giorgi,
  • Francesca Binacchi,
  • Carlo Marotta,
  • Damiano Cirri,
  • Chiara Gabbiani and
  • Alessandro Pratesi

29 December 2022

Although important progress has been made, cancer still remains a complex disease to treat. Serious side effects, the insurgence of resistance and poor selectivity are some of the problems associated with the classical metal-based anti-cancer therapi...

  • Article
  • Open Access
5 Citations
4,030 Views
14 Pages

Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer

  • Cristina Nieto-Jimenez,
  • Ana Alcaraz-Sanabria,
  • Sandra Martinez-Canales,
  • Veronica Corrales-Sanchez,
  • Juan Carlos Montero,
  • Miguel Burgos,
  • Miriam Nuncia-Cantarero,
  • Atanasio Pandiella,
  • Eva M. Galan-Moya and
  • Alberto Ocaña

27 November 2020

Basal-like breast cancer is an incurable disease with limited therapeutic options, mainly due to the frequent development of anti-cancer drug resistance. Therefore, identification of druggable targets to improve current therapies and overcome these r...

  • Review
  • Open Access
36 Citations
6,850 Views
28 Pages

Chemistry of Schiff base (SB) ligands began in 1864 due to the discovery made by Hugo Schiff (Schiff, H., Justus Liebigs Ann. der Chemie 1864, 131 (1), 118–119). However, there is still a vivid interest in coordination compounds based on imine...

  • Review
  • Open Access
5 Citations
4,867 Views
19 Pages

Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens

  • Simonetta I. Gaumond,
  • Gabriela E. Beraja,
  • Isabella Kamholtz,
  • Lina M. Ferrari,
  • Rami H. Mahmoud and
  • Joaquin J. Jimenez

26 January 2025

Background/Objectives: Ovarian cancer is the fifth most common cancer among women, with an estimated 19,680 new cases projected in 2024. Adjuvant chemotherapy remains the standard treatment for epithelial ovarian cancers but is frequently associated...

  • Article
  • Open Access
3 Citations
3,247 Views
15 Pages

In Cellulo Evaluation of the Therapeutic Potential of NHC Platinum Compounds in Metastatic Cutaneous Melanoma

  • Elsa Charignon,
  • Mathilde Bouché,
  • Caroline Clave-Darcissac,
  • Georges Dahm,
  • Gabriel Ichim,
  • Anthony Clotagatide,
  • Hichem C. Mertani,
  • Philippe Telouk,
  • Julie Caramel and
  • Claire Billotey
  • + 3 authors

22 October 2020

We describe here the evaluation of the cytotoxic efficacy of two platinum (II) complexes bearing an N-heterocyclic carbene (NHC) ligand, a pyridine ligand and bromide or iodide ligands on a panel of human metastatic cutaneous melanoma cell lines repr...

  • Feature Paper
  • Article
  • Open Access
6 Citations
2,306 Views
15 Pages

NMR Magnetic Shielding in Transition Metal Compounds Containing Cadmium, Platinum, and Mercury

  • Andy D. Zapata-Escobar,
  • Alejandro F. Maldonado,
  • Jose L. Mendoza-Cortes and
  • Gustavo A. Aucar

In this article, we delve into the intricate behavior of electronic mechanisms underlying NMR magnetic shieldings σ in molecules containing heavy atoms, such as cadmium, platinum, and mercury. Specifically, we explore PtXn−2 (X = F, Cl, B...

  • Article
  • Open Access
2 Citations
2,064 Views
19 Pages

Unraveling Novel Strategies in Mesothelioma Treatments Using a Newly Synthetized Platinum(IV) Compound

  • Cristina Favaron,
  • Ludovica Gaiaschi,
  • Claudio Casali,
  • Fabrizio De Luca,
  • Federica Gola,
  • Margherita Cavallo,
  • Valeria Ramundo,
  • Elisabetta Aldieri,
  • Gloria Milanesi and
  • Maria Grazia Bottone
  • + 2 authors

Malignant mesothelioma is a rare tumor associated with asbestos exposure. Mesothelioma carcinogenesis is related to enhanced reactive oxygen species (ROS) production and iron overload. Despite the recent advances in biomedical sciences, to date the o...

  • Article
  • Open Access
52 Citations
12,360 Views
9 Pages

Effects of High-Humidity Aging on Platinum, Palladium, and Gold Loaded Tin Oxide—Volatile Organic Compound Sensors

  • Toshio Itoh,
  • Ichiro Matsubara,
  • Masahiro Kadosaki,
  • Yuichi Sakai,
  • Woosuck Shin,
  • Noriya Izu and
  • Maiko Nishibori

6 July 2010

This study is an investigation of high-humidity aging effects on the total volatile organic compound (T–VOC) gas-sensing properties of platinum, palladium, and gold-loaded tin oxide (Pt,Pd,Au/SnO2) thick films. The sensor responses of the high-humidi...

  • Feature Paper
  • Article
  • Open Access
32 Citations
4,064 Views
15 Pages

Role of the Metal Center in the Modulation of the Aggregation Process of Amyloid Model Systems by Square Planar Complexes Bearing 2-(2′-pyridyl)benzimidazole Ligands

  • Daniele Florio,
  • Ilaria Iacobucci,
  • Giarita Ferraro,
  • Ahmed M. Mansour,
  • Giancarlo Morelli,
  • Maria Monti,
  • Antonello Merlino and
  • Daniela Marasco

12 October 2019

The effect of analogue Pd(II)-, Pt(II)-, and Au(III) compounds featuring 2-(2′-pyridyl)benzimidazole on the aggregation propensity of amyloid-like peptides derived from Aβ and from the C-terminal domain of nucleophosmin 1 was investigated....

  • Article
  • Open Access
5 Citations
2,725 Views
18 Pages

Incorporation of N7-Platinated Guanines into Thermus Aquaticus (Taq) DNA Polymerase: Atomistic Insights from Molecular Dynamics Simulations

  • Federica De Castro,
  • Giada Ciardullo,
  • Francesco Paolo Fanizzi,
  • Mario Prejanò,
  • Michele Benedetti and
  • Tiziana Marino

In this work, we elucidated some key aspects of the mechanism of action of the cisplatin anticancer drug, cis-[Pt(NH3)2Cl2], involving direct interactions with free nucleotides. A comprehensive in silico molecular modeling analysis was conducted to c...

  • Article
  • Open Access
20 Citations
3,195 Views
16 Pages

Synthesis and Evaluation of the Cytotoxic Activity of Water-Soluble Cationic Organometallic Complexes of the Type [Pt(η1-C2H4OMe)(L)(Phen)]+ (L = NH3, DMSO; Phen = 1,10-Phenanthroline)

  • Federica De Castro,
  • Erika Stefàno,
  • Danilo Migoni,
  • Giorgia N. Iaconisi,
  • Antonella Muscella,
  • Santo Marsigliante,
  • Michele Benedetti and
  • Francesco P. Fanizzi

Starting from the [PtCl(η1-C2H4OMe)(phen)] (phen = 1,10-phenanthroline, 1) platinum(II) precursor, we synthesized and characterized by multinuclear NMR new [Pt(η1-C2H4OMe)(L)(phen)]+ (L = NH3, 2; DMSO, 3) complexes. These organometallic species, pote...

  • Article
  • Open Access
27 Citations
4,406 Views
29 Pages

Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms

  • Jana Hildebrandt,
  • Norman Häfner,
  • Daniel Kritsch,
  • Helmar Görls,
  • Matthias Dürst,
  • Ingo B. Runnebaum and
  • Wolfgang Weigand

(1) Background: Ruthenium and osmium complexes attract increasing interest as next generation anticancer drugs. Focusing on structure-activity-relationships of this class of compounds, we report on 17 different ruthenium(II) complexes and four promis...

  • Article
  • Open Access
4 Citations
3,924 Views
13 Pages

14 May 2022

We describe occurrences of platinum-group minerals (PGM) and an uncommon mineral enriched in Cl, and provide a brief review of Cl-bearing minerals associated with basic–ultrabasic complexes. An unusual phosphohedyphane-like phase (~30 µm)...

  • Article
  • Open Access
7 Citations
3,408 Views
23 Pages

Compound C Inhibits Ovarian Cancer Progression via PI3K-AKT-mTOR-NFκB Pathway

  • Alia Ghoneum,
  • Daniela Gonzalez,
  • Hesham Afify,
  • Junjun Shu,
  • Abigail Hegarty,
  • Jemima Adisa,
  • Michael Kelly,
  • Samuel Lentz,
  • Freddie Salsbury and
  • Neveen Said

18 October 2022

Epithelial Ovarian cancer (OvCa) is the leading cause of death from gynecologic malignancies in the United States, with most patients diagnosed at late stages. High-grade serous cancer (HGSC) is the most common and lethal subtype. Despite aggressive...

  • Article
  • Open Access
9 Citations
4,395 Views
25 Pages

12 October 2020

Au, Pt, and Pt-Au catalysts supported on Al2O3 and CeO2-Al2O3 were studied in the oxidation of dichloromethane (DCM, CH2Cl2). High DCM oxidation activities and HCl selectivities were seen with all the catalysts. With the addition of Au, remarkably lo...

  • Brief Report
  • Open Access
22 Citations
2,721 Views
8 Pages

Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study

  • Florian Moik,
  • Nick van Es,
  • Florian Posch,
  • Marcello Di Nisio,
  • Thorsten Fuereder,
  • Matthias Preusser,
  • Ingrid Pabinger and
  • Cihan Ay

3 September 2020

Gemcitabine and platinum-based agents could increase the risk of venous thromboembolism (VTE) in patients with cancer. We evaluated the additive predictive utility of these agents towards cancer-associated VTE beyond a recently developed and external...

  • Article
  • Open Access
9 Citations
3,419 Views
11 Pages

Although Pt(II)-based drugs are widely used to treat cancer, very few molecules have been approved for routine use in chemotherapy due to their side-effects on healthy tissues. A new approach to reducing the toxicity of these drugs is generating a pr...

  • Review
  • Open Access
13 Citations
2,760 Views
14 Pages

Recently Reported Biological Activities and Action Targets of Pt(II)- and Cu(II)-Based Complexes

  • Cristhian Eduardo Maciel-Flores,
  • Juan Antonio Lozano-Alvarez and
  • Egla Yareth Bivián-Castro

29 February 2024

Most diseases that affect human beings across the world are now treated with drugs of organic origin. However, some of these are associated with side effects, toxicity, and resistance phenomena. For the treatment of many illnesses, the development of...

  • Feature Paper
  • Article
  • Open Access
10 Citations
2,672 Views
22 Pages

Pt/CeMnOx/Diatomite: A Highly Active Catalyst for the Oxidative Removal of Toluene and Ethyl Acetate

  • Linlin Li,
  • Yuxi Liu,
  • Jiguang Deng,
  • Lin Jing,
  • Zhiquan Hou,
  • Ruyi Gao and
  • Hongxing Dai

30 March 2023

Pt nanoparticles and a CeMnOx composite were loaded on the surface of the natural diatomite material to generate the Pt/CeMnOx/diatomite using the redox precipitation and impregnation methods. The physicochemical properties of the catalysts were char...

  • Communication
  • Open Access
1,286 Views
12 Pages

Description of a Non-Canonical AsPt Blue Species Originating from the Aerobic Oxidation of AP-1 in Aqueous Solution

  • Damiano Cirri,
  • Tiziano Marzo,
  • Piero Mastrorilli,
  • Valentina Petrelli,
  • Stefano Todisco,
  • Elvira De Giglio,
  • Cristina Gellini,
  • Marilena Ricci,
  • Alessandro Pratesi and
  • Luigi Messori

The peculiar behavior of arsenoplatin-1, ([Pt(µ-NHC(CH3)O)2ClAs(OH)2], AP-1), in aqueous solution and the progressive appearance of a characteristic and intense blue color led us to carry out a more extensive investigation to determine the natu...

  • Article
  • Open Access
1,577 Views
23 Pages

High-Performance Pd-Pt/α-MnO2 Catalysts for the Oxidation of Toluene

  • Ning Dong,
  • Wenjin Wang,
  • Xuelong Zheng,
  • Huan Liu,
  • Jingjing Zhang,
  • Qing Ye and
  • Hongxing Dai

5 August 2025

Herein, α-MnO2-supported Pt-Pd bimetal (xPd-yPt/α-MnO2; x and y are the weight loadings (wt%) of Pd and Pt, respectively; x = 0, 0.23, 0.47, 0.93, and 0.92 wt%; and y = 0.91, 0.21, 0.46, 0.89, and 0 wt%) catalysts were prepared using the...

  • Review
  • Open Access
1 Citations
1,198 Views
11 Pages

Platinum-Induced Ototoxicity in Pediatric Cancer Patients: A Comprehensive Approach to Monitoring Strategies, Management Interventions, and Future Directions

  • Antonio Ruggiero,
  • Alberto Romano,
  • Palma Maurizi,
  • Dario Talloa,
  • Fernando Fuccillo,
  • Stefano Mastrangelo and
  • Giorgio Attinà

Platinum-induced ototoxicity constitutes a significant adverse effect in pediatric oncology, frequently resulting in permanent hearing impairment with profound implications for quality of life, language acquisition, and scholastic performance. This c...

  • Article
  • Open Access
4 Citations
3,404 Views
12 Pages

20 December 2021

Acute kidney injury (AKI) complicates the dosing strategies of oxaliplatin (L-OHP) and the requirement for L-OHP dose reduction in patients with renal failure remains controversial. The objective of this study is to assess the impact of AKI on the ph...

  • Article
  • Open Access
1 Citations
2,648 Views
19 Pages

Unnamed Pt(Cu0.67Sn0.33) from the Bolshoy Khailyk River, Western Sayans, Russia, and a Review of Related Compounds and Solid Solutions

  • Andrei Y. Barkov,
  • Luca Bindi,
  • Erick A. Juárez-Arellano,
  • Nobumichi Tamura,
  • Gennadiy I. Shvedov,
  • Chi Ma and
  • Robert F. Martin

8 November 2021

We describe a potentially new species of a platinum cupride–stannide mineral (PCSM) of composition Pt(Cu0.67Sn0.33). It occurs in a placer deposit in the River Bolshoy Khailyk, southern Krasnoyarskiy kray, Russia. A synthetic equivalent of PCSM was o...

  • Article
  • Open Access
6 Citations
3,109 Views
16 Pages

Oxaliplatin (L-OHP) is widely prescribed for treating gastroenterological cancer. L-OHP-induced peripheral neuropathy is a critical toxic effect that limits the dosage of L-OHP. An ideal chemotherapeutic strategy that does not result in severe periph...

  • Article
  • Open Access
7 Citations
4,528 Views
22 Pages

Simple Trans-Platinum Complex Bearing 3-Aminoflavone Ligand Could Be a Useful Drug: Structure-Activity Relationship of Platinum Complex in Comparison with Cisplatin

  • Małgorzata Fabijańska,
  • Magdalena Orzechowska,
  • Agnieszka J. Rybarczyk-Pirek,
  • Justyna Dominikowska,
  • Alicja Bieńkowska,
  • Maciej Małecki and
  • Justyn Ochocki

Following previous studies devoted to trans–Pt(3-af)2Cl2, in this paper, the molecular structure and intermolecular interactions of the title complex are compared with other cisplatin analogues of which the crystal structures are presented in t...

  • Review
  • Open Access
24 Citations
3,832 Views
19 Pages

The Challenging Treatment of Cisplatin-Resistant Tumors: State of the Art and Future Perspectives

  • Giulia Coffetti,
  • Martina Moraschi,
  • Giorgio Facchetti and
  • Isabella Rimoldi

12 April 2023

One of the main problems in chemotherapy using platinum drugs as anticancer agents is the resistance phenomenon. Synthesizing and evaluating valid alternative compounds is challenging. This review focuses on the last two years of progress in the stud...

of 10